Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Prevention With Fenretinide in Young Women at Genetic and Familil Risk. A Phase III Randomized Clinical Trial

NCT01479192 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT01479192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01479192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Prevention With Fenretinide in Young Women at Genetic and Familil Risk. A Phase III Randomized Clinical Trial
Lead sponsor
European Institute of Oncology
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2009
Completion date
December 31, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk cancer